A recent roundtable discussion focused on how today's healthcare leaders can "begin to dismantle the systems that perpetuate inequities in medicine and build new systems that promote diversity, equity and inclusive excellence."

Backed with financial support and technical prowess from the U.S. Department of Energy, NorthStar Medical Radioisotopes has shown it can produce, at scale, a critical nuclear imaging radiotracer without using highly enriched uranium.

Spectrum Laboratory Products is voluntarily recalling the lots after customer complaints found the adrenaline to be discolored.

HHS is moving forward with drug price negotiations afforded to CMS under the Inflation Reduction Act.

HB 575 would remove financial barriers for women who are recommended to undergo supplemental breast imaging, such as an MRI, CT or ultrasound, when the exams are deemed medically necessary.

The UK's Home Secretary recently proposed the use of X-ray, CT and/or MRI for age checks to determine which migrants are, in fact, children and which ones might be posing as children in an attempt to remain in the country.

The U.S. Food and Drug Administration (FDA) approved a new drug treatment for Alzheimer’s disease, Leqembi (lecanemab).

Amazon has overcome another step toward acquiring primary care group One Medical for $3.9 billion after the Oregon Housing Authority cleared the deal.